IGC - India Globalization Capital Inc Stock Price, Fair Value and News

$0.30-0.01 (-3.23%)

Market Closed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

IGC Price Action

Last 7 days

-6.2%

Last 30 days

-25%

Last 90 days

-31.8%

Trailing 12 Months

-16.7%

IGC RSI Chart

IGC Valuation

Market Cap

27.9M

Price/Earnings (Trailing)

-4.34

Price/Sales (Trailing)

25.19

EV/EBITDA

-4.58

Price/Free Cashflow

-4.95

IGC Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

IGC Fundamentals

IGC Revenue

Revenue (TTM)

1.1M

Rev. Growth (Yr)

-53.64%

Rev. Growth (Qtr)

-41.77%

IGC Earnings

Earnings (TTM)

-6.4M

Earnings Growth (Yr)

-6.06%

Earnings Growth (Qtr)

-13.88%

IGC Profitability

Operating Margin

46.20%

EBT Margin

-582.82%

Return on Equity

-79.4%

Return on Assets

-65.94%

Free Cashflow Yield

-20.19%

IGC Investor Care

Shares Dilution (1Y)

19.91%

Diluted EPS (TTM)

-0.07

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2025	1.3M	1.3M	1.1M	0
2024	1.3M	1.1M	1.2M	1.2M
2023	911.5K	1.3M	1.3M	1.2M
2022	397.0K	532.0K	678.0K	868.0K
2021	898.0K	391.0K	322.0K	356.0K
2020	4.1M	3.0M	1.3M	846.0K
2019	5.1M	5.3M	6.3M	5.6M
2018	2.2M	3.6M	4.2M	4.7M
2017	793.5K	557.9K	630.7K	1.1M
2016	6.4M	4.8M	2.9M	2.1M
2015	7.7M	8.8M	8.7M	7.3M
2014	2.3M	3.6M	5.0M	6.3M
2013	8.0M	7.9M	7.7M	3.8M
2012	4.2M	4.4M	4.8M	7.8M
2011	4.1M	4.0M	3.2M	3.7M
2010	0	0	0	7.5M

Get all data in R, Python etc through our Historical Stock Data APIs

About India Globalization Capital Inc

IGC Pharma, Inc., a clinical stage biotechnology company, engages in developing cannabinoid-based formulations for treating diseases and conditions, including Alzheimer's disease, dysmenorrhea, premenstrual syndrome, and chronic pain. The company has two investigational drug assets targeting Alzheimer's disease comprising IGC-AD1, which is in a Phase 2B clinical trial as a treatment for agitation in dementia due to Alzheimer's; and TGR-63 that is in pre-clinical development. It also markets Holief, a wellness brand that targets women experiencing premenstrual syndrome and menstrual cramps. The company was formerly known as India Globalization Capital, Inc. and changed its name to IGC Pharma, Inc. in March 2023. The company was incorporated in 2005 and is headquartered in Potomac, Maryland.

CEO	Mr. Ram Mukunda
WEBSITE	https://igcpharma.com
SECTOR	Healthcare
INDUSTRY	Biotechnology
EMPLOYEES	61

India Globalization Capital Inc Frequently Asked Questions

What is the ticker symbol for India Globalization Capital Inc? What does IGC stand for in stocks?

IGC is the stock ticker symbol of India Globalization Capital Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of India Globalization Capital Inc (IGC)?

As of Wed Dec 03 2025, market cap of India Globalization Capital Inc is 27.86 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of IGC stock?

You can check IGC's fair value in chart for subscribers.

Is India Globalization Capital Inc a good stock to buy?

The fair value guage provides a quick view whether IGC is over valued or under valued. Whether India Globalization Capital Inc is cheap or expensive depends on the assumptions which impact India Globalization Capital Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for IGC.

What is India Globalization Capital Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed Dec 03 2025, IGC's PE ratio (Price to Earnings) is -4.34 and Price to Sales (PS) ratio is 25.19. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. IGC PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on India Globalization Capital Inc's stock?

In the past 10 years, India Globalization Capital Inc has provided 0.018 (multiply by 100 for percentage) rate of return.